Judge Tacks $6M In Delay Damages To $70M Risperdal Award

Law360, New York (August 12, 2016, 6:14 PM EDT) -- A Pennsylvania state judge agreed Wednesday to add about $6.7 million in delay damages to a $70 million award handed down by a jury last month in a case over allegations that a Johnson & Johnson unit's antipsychotic Risperdal caused an adolescent boy to grow female breasts.

In a one-page order, Philadelphia County Court of Common Pleas Judge Paula A. Patrick ordered Janssen Pharmaceuticals Inc. to cough up an additional $6.66 million in delay damages to plaintiff Andrew Yount and his family after they won a $70 million jury verdict last month.

Counsel for the family asked the court to increase...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!